Novartis signs deal with iTheranostics to develop, commercialise compounds targeting FAP
Expands Novartis Oncology radioligand pipeline with exclusive worldwide rights to develop and commercialise therapeutic…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.